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Abstract

Background: Data suggest that African Americans lose less weight and show fewer

improvements in cardiovascular diseases such as blood pressure following gastric bypass
surgery (GBP).
Objective: The purpose of this study was to describe differences in weight loss between

Caucasian and African American patients following GBP and to identify if these
differences are related to dietary intake. This study also sought to identify differences in
blood pressure and serum lipid levels between African Americans and Caucasians after
GBP.
Methods and Subjects: This was a retrospective database review of a sample of 84 adult

patients, 24 African American and 60 Caucasian women and men between the ages of 33
and 53 years. All subjects had GBP surgery in 2001 at the Bariatric Surgery Program at
Boston Medical Center (BMC) in Boston, MA and were followed for one year
postoperatively. Patients were excluded if weight data were missing at baseline, three
months and one year following GBP. A total of 9 African Americans and 41 Caucasians
provided data at all three time points and were included in the study. Weight change was
calculated using percent of initial body weight and change in body mass index (BMI).
Differences in dietary intake were determined using dietary records completed by the
patients or by patient dietary recalls collected by the dietitian. Blood pressure, total
cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and
triglyceride levels at baseline and one year were abstracted from the GBP database.

Results: There were no differences in baseline characteristics between African

Americans and Caucasians. Caucasians lost more weight (BMI reduced from 56 ± 12 to
34 ± 8 at one year after surgery with a percent weight loss of 38±8) than African
Americans (BMI reduced from 54 ± 8 to 40 ± 11 with a percent weight loss of 26 ± 10)
(p < .001). There were main effects for time and race on weight loss expressed as change

in BMI and percent weight loss at one year following GBP (p < .001) as well as an
interaction between and within race weight loss (p < .001). There were no differences
between races for diet, blood pressure, or serum lipids. However, there were differences
within race for each of these variables (p < .05).
Conclusions: These data demonstrate that GBP promotes significant weight loss among

morbidly obese African Americans and Caucasians. African Americans lost less weight
at one year after GBP; however, dietary parameters and cardiovascular risk indices were
not significantly different between races. Prospective intervention studies should be
conducted to help clarify the primary etiologies for differential weight loss between races
following GBP. Identification of these causes will help delineate specific interventions
that are sensitive to racial differences, and ultimately optimize the outcome ofbariatric
surgery in an ethnically diverse patient population.
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Introduction

The incidence of obesity in the United States (US) has reached epidemic
proportions and is considered a significant public health threat. The National Health
and Nutrition Examination Survey (NHANES) of 1999-2000 reported that 64.5% of
adult Americans are overweight with 30% considered obese. Despite increased
medical awareness of obesity and a multitude of intervention programs, the prevalence
of obesity has increased more than 75% during the past 25 years (1) with a mortality
rate of 300,000 deaths annually (2). Obesity predisposes individuals to multiple comorbid conditions such as cardiovascular disease (CVD) and type 2 diabetes. The
incidence of diabetes has increased over the past ten years with 25% of this increase
associated with obesity (3). Hypertension and dyslipidemia are also associated with
obesity. The primary cause of mortality associated with elevated BMI is
cardiovascular disease (4).
Although traditional diets are effective for weight loss between 2-3 kilograms, (5)
intensive programs with long-term maintenance including diet, exercise, and
behavioral change strategies can produce 5-10 % weight loss (6). This is generally
ineffective for Class III obesity (BMI 2: 40 kg/m 2) with concurrent co-morbid
conditions (7). The negative impact of Class III obesity on morbidity and mortality in
the US cannot be ignored. GBP has been found to be effective for morbidly obese
patients with subsequent improvements in cardiovascular and metabolic sequelae (7).
The Roux-en-Y gastric bypass surgery (RYGBP) is now recognized as the gold

standard treatment for patients with Class III obesity with concurrent co-morbid
conditions. The RYGBP promotes weight loss by limiting gastric volume and the rate
of gastric emptying with resultant early satiety (8). This procedure has demonstrated
sustainable weight loss with manageable complications both in the short- and longterm (9).
Studies have demonstrated significant improvements in cardiovascular risk
factors and diabetes among Caucasian morbidly obese patients following GBP (10).
Similar studies in other ethnic groups remain limited. This might be related to the less
frequent use ofbariatric surgery in minority populations (11,12). A small number of
recent clinical studies suggest that morbidly obese African American women lose less
weight and show less improvement in blood pressure than Caucasian morbidly obese
women following GBP (9). Although there might be metabolic differences between
morbidly obese African Americans and Caucasians, behavioral factors such as dietary
intake might also account for differences in weight reduction (13). Clarification of
these differences are important for optimizing the post-surgical treatment of morbidly
obese African Americans. Due to these racial disparities, it is important that weight
loss interventions be targeted toward ethnic needs.
We conducted the following study to compare weight loss between African
American and Caucasian morbidly obese patients following GBP surgery in an urban
obesity treatment referral center. We also examined differences in dietary intake and
cardiovascular risk factors in this patient population before and after weight loss.
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Methods

Gastric Bypass Program Protocol

Screening

The bariatric surgery program at BMC was launched in 1999, and has since
performed more than 600 operations. Patients are referred by their primary care
physician to the Bariatric Surgery Program for screening by the bariatric surgeon, a
physician board certified in nutrition, a psychologist, and the bariatric registered
dietitian for surgical clearance. If cleared by all members of the team, preparation for
surgery includes preoperative weight loss, preoperative and postoperative nutrition
education, and diagnostic testing. Patients are instructed to follow a low fat, high fiber
diet prior to surgery to help promote preoperative weight loss and healthy eating
behaviors. Patients are scheduled for surgery approximately nine to 12 months
following their initial appointment with the surgeon and must attend at least one
gastric bypass support group meeting.

Perioperative and Postoperative Phases

The hospital stay following surgery is approximately five to six days. The
surgical procedure performed is a distal RYGB with a 100 to 150 cm Roux limb
length and 30 mL pouch created in the proximal portion of the stomach. Patients are
NPO for 48 hours following surgery with advancement to PO ifthe upper GI series
presents as normal. Subsequently, patients are advanced to sips of water (Stage I)
followed by a no concentrated sweet clear liquid diet (Stage II), and then to a no
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concentrated sweet full liquid diet (Stage III), as tolerated. Patients are discharged on a
Stage III diet and continue to follow this diet at home for three weeks. Patients are
advised to begin taking chewable multivitamin/mineral and calcium supplements.
Postoperative follow-up visits are scheduled with both the surgeon and the dietitian
ten to 14 days following their hospital discharge. At this time, patients will be
instructed to begin a high protein soft solid diet (Stage IV) at three weeks after surgery
as tolerated. Patients remain on soft solids for approximately one month, and are then
scheduled with the dietitian to advance to a low fat solid diet (Stage V), as tolerated.
Patients continue on the low fat diet indefinitely with modifications made as needed at
follow-up visits.
Dietary assessment tools, including the Exchanges for Weight Management
(14) and dietary logs created by the bariatric dietitian, were provided to patients at
their initial postoperative visit. The Exchanges for Weight Management provide
patients with macronutrient analyses including the caloric density of their food and
beverage intake. Patients were provided dietary logs to record energy, protein, and
fluid intake. During each follow-:up dietitian visit, food and beverage models were
used as visual aids to better assess the reliability of portion sizes noted in patientreported dietary logs or recalls. The bariatric dietitian reviewed all dietary logs and
recalls. Patients are advised to consume a minimum of 60 grams of protein from high
biological value sources and two liters or more of sugar-free non-caffeinated fluids
daily. Patients are encouraged to document energy intake if there is a decrease in the
rate or degree of their weight loss. Postoperative follow-up visits with the surgeon are
scheduled every four to six weeks for the first year or until patients are weight stable,
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and yearly thereafter. Postoperative follow-up visits with the dietitian occur monthly
for the first six months and every six months thereafter.

Subjects
This retrospective study included African American and Caucasian patients
who had GBP in 2001 at BMC located in Boston, Massachusetts. A total of 84 patients
completed surgery during this period including 52% Caucasian women, 20%
Caucasian men, 23% African American women, and 5% African American men
between the ages of 31-55 years of age. Patients were excluded if baseline, three
months or one year postoperative weight data were missing. A total of nine African
Americans and 41 Caucasians provided complete data and were included in this study.
There were no differences in age, gender, and proportion with dyslipidemia,
hypertension, and diabetes mellitus between the 50 subjects providing complete data
and the 34 subjects excluded from the study for incomplete data. The non-completers
included 19 Caucasians and 15 African Americans. Those subjects presenting with
incomplete weight data had a lower preoperative mean BMI (50 ± 9) compared to
those with complete data.
The University of Rhode Island and Boston Medical Center Institutional
Review Board approved this study.

Measurements
Body weight in kilograms was measured at baseline (preoperative visit), three
months and one year after GBP. Body weight was measured using a Scale-Tronix
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digital scale calibrated every 12 weeks. Height was measured in centimeters using an
attached vertical rod.
The bariatric dietitian collected dietary records or dietary recalls from patients
at baseline and each postoperative visit. Dietary protein and energy intake for each

I
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visit were calculated using the Exchange Lists for Weight Management (14) and
Bowes' and Church's Food Values of Portions Commonly Used (15).
Blood pressure and lipid profiles in both ethnic groups were assessed at
baseline and one year following GBP. Blood pressure was.measured using a
baumamometer Standby model (W.A. Baum CO, Inc.) in a postural position. A
certified phlebotomist collected blood samples with subjects in a postural position.
Blood was taken from an antecubital vein following a 12-hour fast. Low-density
lipoproteins (LDL) were calculated using the Friedewald equation if triglycerides were
below 400 mg/dL (16). Total cholesterol, high-density lipoproteins (HDL), and
triglyceride levels were measured using the Ektachem DT II System. HDL cholesterol
levels were then determined by the precipitation method (17).

Data Analysis and Statistics

Data were collected from the GBP database and analyzed using the SPSS
software version 10.5. Means and standard deviations for all parameters were
calculated. Weight and dietary intake were assessed at baseline, three months, and one
year after GBP. Primary comparisons were changes in these variables compared
between the African American and Caucasian groups at three months and one year
following GBP using ANOVA for repeated measures with ethnicity as a between
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subjects factor and time as a within subjects factor. This determined changes over time
in the above variables as well as ethnicity main effects and ethnicity by time
interactions. Weight data were expressed as percent of initial body weight and BMI.
Baseline body weight was defined as subject's preoperative weight taken two weeks
prior to surgery. Protein intake was expressed as percentage of total kilocalories and
energy intake was expressed as kilocalories per kilogram of body weight. Weight and
protein and energy intake were assessed at three months and one year after surgery.
Changes in health parameters were assessed at baseline and one year after GBP by
paired t-tests comparing changes within and between groups.
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Results

Subjects
Baseline anthropometric and demographic characteristics of participants
providing complete weight data are summarized in Table 1. There were no differences
between race in age, BMI, female/male ratio, and prevalence of dyslipidemia,
hypertension, and diabetes. All subjects had at least one of the noted comorbidities
with hypertension (4 7 %) being the most prevalent. The average patient seeking
bariatric surgery was 43 years old with a BMI of 55 kg/m 2 .
Subjects providing incomplete weight data at three months and one year after
GBP were not different by race in all measured variables, except for a lower baseline
BMI, compared to those subjects providing complete weight data.

Weight Loss
The observation period for this study was one year following GBP. The mean
preoperative BMI for African Americans and Caucasians was 54

± 8 (N =

9) and 56

±

12 (N = 41), respectively. Both African Americans and Caucasians significantly
reduced their BMI and percent body weight (p < .001). There was an overall effect of
'

race on BMI and percent weight loss with Caucasians losing more weight than African
Americans (P < .001). Post hoc analyses demonstrated no ethnic differences in BMI
and percent weight loss between the races at baseline or three months following
surgery but differences were observed at one year (p < .05) as shown in Table 2. On
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Caucasian patients lost six percent more weight at three months (NS) and 12

% more weight at one year (p < .001) after GBP than African Americans.

Dietary Intake
As shown in Table 3, African Americans and Caucasians did not differ in
dietary intake after GBP as measured by energy (kilocalories) per kilogram and
percentage of energy as protein at three months and one year following surgery. The
mean energy intake in kilocalories at baseline and one year after GBP was lower in
Caucasians (2596 ± 588 and 1123 ± 349, respectively) than in African Americans
(2700 ± 722 and 1368 ± 349, respectively). However, at three months after surgery,
Caucasians consumed more kilocalories than African Americans (704 ± 238 and 621 ±
127, respectively). African Americans had a 70 % and 33 % decrease in energy intake
at three months and one year after GBP, respectively. Caucasians had a 67 % and 31
% decrease in energy intake at three months and one year, respectively. The mean

protein intake in grams at baseline and one year after surgery was higher in African
Americans (83 ± 17 and 61 ± 12; respectively) than Caucasians (82 ± 19 and 59 ± 12,
respectively). There was no difference in protein inake between races at three months
after surgery. However, Caucasians consumed more grams of protein than African
Americans (Caucasians 62

± 14 and African Americans 53 ± 9; p > .05). Both races

consumed significantly less energy and more kilocalories as protein at three months (p

< .001, P < .001, respectively) and one year (p < .001, p < .001, respectively) after
surgery compared to their intake prior to surgery. Using ANOV A for repeated
measures, main effects of race were not indicated for changes in energy per kilogram
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and percentage of energy from protein one year after GBP. However, main effects of
time on energy intake per kilogram and percentage of kilocalories as protein were
significant for African Americans and Caucasians (p < .001).

Cardiovascular Risk Differences

Differences in blood pressure and lipid values between African Americans and
Caucasians are detailed in Table 4. There were significant improvements in blood
pressure and all lipid serum indices within both races one year following surgery (p <
.01) indicating decreased cardiovascular risks. There were no differences between
races in diastolic and systolic blood pressure at baseline and one year following GBP.
Similarly, there were no differences between races in serum total cholesterol, HDL
cholesterol, calculated LDL cholesterol, and triglycerides at baseline and one year
following surgery. ANOV A for repeated measures did not show main effects of race
for blood pressure (systolic and diastolic) and serum lipids (total cholesterol, HDL
cholesterol, LDL cholesterol, and triglycerides).
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Discussion

This study showed significant weight loss at one year following GBP among
the entire sample. There were differences in weight loss between races with African
Americans losing 12% less weight compared to Caucasians at one year after GBP;
African Americans and Caucasians lost a mean total of 44 and 61 kilograms at one
year after surgery, respectively. These results are similar to those found by Sugerman
and Latner et. al. (18, 19). The etiology for this difference is still unclear; however, it
has been suggested that genetic, environmental, behavioral, psychosocial, cultural, and
metabolic differences contribute to this disparity (20).
This study observed a significant decrease in energy intake at three months and
one year within each race following GBP. This is expected following GBP due to the
reduced gastric pouch capacity (21, 22). Our findings of similar energy intake between
races at each observed time point following GBP suggest the possibility of metabolic
differences between races. Other studies have found that African American women
appear to adapt to energy deficits more efficiently than Caucasian women; they
require fewer calories for weight maintenance and have a reduced rate of weight loss
on hypocaloric diets compared to Caucasian women (23-25). Carpenter et. al. found
lower basal metabolic rates and activity energy expenditure (AEE) in African
Americans (26). Weisner et. al. found that AEE was significantly different between
races with African Americans having a lower AEE following weight loss. Caucasians
showed greater improvements in V02 max, physical activity, and energy expenditure
(EE) compared to their African American counterparts in response to diet and exercise
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. ht loss interventions (27). These findings have been shown in other studies (28,
we1g
29) suggesting decreased weight loss efficiency among African American women
compared to Caucasian women. Our study did not evaluate differences in physical
exercise and energy expenditure. Future intervention studies exploring the behavioral
and metabolic effects on weight loss are needed to further understand the influences of
ethnicity on weight reduction following bariatric surgery.
Results from this study showed a significant decrease in energy intake with an
increase in percentage of kilocalories from protein within each race at three months
and one year after GBP. Moize and colleagues also observed these postoperative
dietary changes. Due to the reduced capacity of the gastric pouch energy intake
significantly decreases, especially during the first six months to a year following GBP.
High biological value protein sources are encouraged to promote postoperative healing
and to preserve and restore lean body tissue (30). Modular protein supplements were
recommended if daily protein intake was less than 60 grams daily, especially during
the first six months following surgery. Six out of the nine African Americans
consumed less than 60 grams .of protein at three months after surgery, potentially
resulting in decreased visceral protein stores and wound healing. Despite the greater
weight loss among Caucasians, we found no ethnic differences in energy and
percentage of calories from protein at each observed time point.

This was also

observed in other studies (31, 32) and might be due to under-reporting of energy
intake among African Africans as shown by Lovejoy et. al. (33). Latner and
colleagues found that African Americans and Caucasians lost 62 % and 80 % of
excess BMI following GBP, respectively, but African Americans consumed overall
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.localories than Caucasians with no differences found in exercise frequency
fewer kl

(1 9). The utility of self-reported dietary intake to assess energy and macronutrient
intake might have lead to a 20-50 % error of actual intake (34), which was a major
limitation in most of these studies. Future research can improve the accuracy of actual
dietary intake by use of doubly labeled water methods (29, 35) or by designing more
controlled dietary interventions.
This study examined ethnic differences in cardiovascular disease risk factors
following GBP. Presently, there are limited data comparing the effect of weight loss
on cardiovascular risk between African Americans and Caucasians following bariatric
surgery (35). Our results did not show differences between race in serum lipid profiles
at baseline and one year following GBP. However, we did find a greater percentage of
African Americans compared to Caucasians with dyslipidemia at baseline (44 % and
35 %, respectively). Finally, HDL levels were greater at baseline and one year
following surgery but were not statistically different between races. The small African
American sample size might have affected the reduced ability of this study to find
statistically significant differences, but the effect of size for race was low suggesting
that a larger sample size might not have found differences . Irrespective of BMI, data
have shown that African Americans as compared to Caucasians have higher HDL
levels with a subsequent lower risk for CVD (36, 37).
Our findings suggest no difference in cardiovascular risk factors between
races. Residori and colleagues reported that African Americans had the highest
incidence of hypertension compared to Caucasians and other ethnic groups
independent ofBMI (20). That study did not examine subjects having undergone
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GBP. Sugerman et. al. found that hypertension improved in most subjects with weight
Joss at one to two years following GBP. However, African Americans responded less
favorably to improvements in hypertension following GBP induced weight loss as
compared to Caucasians (35). There were several limitations of our study. First, the
small sample of African Americans studied compared to Caucasians. We might have
observed the same results as Sugerman et. al. with a larger African American sample
size. Secondly, the effect of medications that subjects might have been taking
indicated by their medical condition was not monitored in this study.
In conclusion, our data confirm that morbidly obese African Americans tend to

Jose less weight following gastric bypass surgery in comparison to Caucasians. These
differences in weight loss appear to be related to lower energy expenditure and not
dietary intake. However, despite smaller weight losses among the African Americans,
improvements in cardiovascular risk factors are similar between the two races.
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Table 1
Baseline Characteristics of Subjects by Race

-

African Americans

Caucasians

9

41

Age (Mean±SD)

43±10

43±10

BMI (Mean±SD)

54±8

56±12

Female/Male %

78/22

73/28

Dyslipidemia %

44

35

Hypertension %

44

50

Diabetes Mellitus %

44

25

N

N =subjects with weight data at baseline, 3 months and 1 year
BMI =body mass index; calculated as kg/m 2
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Table2

Body Mass Indices and Percent of Weight Loss Up to 1 Year Following GBP
African Americans
BMIT*
kg/m2
N

N
N

9

Caucasians

% intial body weight F
( % weight loss )

9

100 (0)

BM1 1*
kg/m2

% initial body weight 2*
(% weight loss)

41

41

56±12

100 (0)

Preop

54±8

Post3
months

50±9

91.4±7.4
(-8.7±7)

48±11

85.4±3.8
(-15.2±5.5)

Post 1
year

ab40±11

73 .9±9.6
ab (-26±9.6)

ab34±8

61.7±7.9
ab (-38±7.9)

All data are means ± SD; N = subjects without missing data
BMI = body mass index; calculated as kg/m 2
Weight loss = % of initial weight
*F (dfhypothesis, df error), p by repeated measures
1. 130 (2, 47), p = 0.000 for time; 7.6 (2, 47), p = 0.001 for race x time
2. 280 (2, 47), p = 0.000 for time; 12.3 (2, 47), p = 0.000 for race x time

Table3

Energy and Protein Intake Before and Up to 1 Year Post GBP.
African Americans

Caucasians

kilocalories/kilogram 1*

% kilocalories from protein 2 *

9

9

41

41

Preop

16±5

13±2

17±4

13±2

Post 3
months

*5±2

**33±8

*6±2

**37±12

Post 1 year

*12±4

**23±7

*12±4

**23±9

N

Kilocalories/kilogram 1 • % kilocalories from protein2 *

N

w

All data are means ± SD; N = subjects without missing data
*F (dfhypothesis, df error), p by repeated measures
1. 126 (2, 45), p = 0.000 for time; 1.530 (2, 45), p = 0.230 for race x time
2. 67 (2, 45), p = 0.000 for time; 0.424 (2, 45), p = 0.657 for race x time

Preoperative and 1 Year Postoperative Cholesterol and Blood Pressure Values
Caucasians

African Americans

Preop

N

Post 1 year

Mean Change(95%Czy1l

Preop

Post 1 year

Mean change 95%(CI) (tl

TC

220±19
(7)

181±33
(7)

-35(-10, -61) *

199±33
(40)

179±35
(40)

-21(-10, -32)*

HDL

56±17
(6)

66±21
(6)

10(25, 5)**

48±10
(33)

54±16
(33)

6(10, 2)**

LDL

132±7
(5)

107±37
(5)

-25(-29, -79)**

120±32
(35)

103±31
(35)

-17(-6, -28)**

TG

130±57
(7)

80±24
(7)

-50(-4, -96)**

159±55
(37)

109±53
(37)

-50(-26, -74)**

Sys

136±18
(9)

117±15
(9)

-19(-3, -35)*

135±23
(41)

123±20
(41)

-12(-6, -1 8)*

Dias

82±7
(9)

70± 8
(9)

-12(-4, -19)*

84± 12
(41)

73±11
(41)

-11 (-7, -15)*

+:-

All data are means± SD; N =subjects without missing data;
TC= total cholesterol; HDL = high density lipoproteins; LDL = low density lipoproteins; TG =triglycerides
Sys = systolic blood pressure; Dias = diastolic blood pressure
( 1) Mean Change = negative markers indicate decreases
*P < .001; **P < .01 within race

Appendices

Appendix A Literature Review

Introduction

The incidence of obesity in the United States (US) has reached epidemic
proportions and is considered a significant public health threat. The National Health
and Nutrition Examination Survey (NHANES) of 1999-2000 reported that 64.5% of
adult Americans are overweight with 30% considered obese. Despite the increased
medical awareness of obesity and a multitude of diet and exercise intervention
programs, obesity prevalence has increased by more than 75% during the past 25 years
(Flegal Km, Carroll MD, Ogen CL, Johnson Cl, 2002) with a mortality rate of 300,000
deaths yearly (Allison DB, Fontaine KR, Manson JE, Stevens J, Vanltalle TB, 1999).

I. Obesity

A. Classification of Obesity and C.omorbidities
According to the World Health Organization (WHO) obesity is a disease that
affects all ages, both genders, and all ethnic groups. WHO classifies weight status
based on BMI, which is defined as weight in kilograms divided by height in meters
squared (WHO, 2000). Obesity is defined as a BMI of ::::30 kg/m2 and morbid obesity
as a BMI of ::::::40 kg/m2 with the risks for morbidity and mortality being greatest at a
BMI of ;::::40 kg/m 2 (WHO, 2000). The diagnosis of diabetes has increased during the
Past ten years with 25% of this increase associated with obesity (Harris ML, Flegal
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J(M, Cowie CC, Eberthardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt
DD 19 98). Hypertension, dyslipidemia, and metabolic syndrome are highly associated
with obesity. The primary causes of mortality associated with elevated BMI are from
cardiovascular diseases (Troiano RP, Frongillo EA, Sobal J, Levitsky DA, 1996).

B. Etiology
Obesity is a condition influenced by genetic, psychosocial, metabolic, cultural,
and behavioral factors (NIH, NHLBI, 1998). Although genetic predisposition plays a
role in the expression of obesity, genetic factors cannot explain the exponential rise in
obesity over the past two decades. Behavioral and environmental factors are the most
probable causes for the expression of genes associated with obesity (Mun EC,
Blackbum GL, Mathews JB, 2001). Some of these factors include reduced physical
activity and the availability of high calorie foods resulting in positive energy balance
(Harnack LJ, Jeffery RW, Boutelle KN, 2000; Flegal Km, Carroll MD, Ogen CL,
Johnson Cl, 2002). Energy intake and output are difficult to quantify, therefore it is
important to further examine all causal factors involved such as cultural,
socioeconomic, psychological, and metabolic influences (Flegal Km, Carroll MD,
Ogen CL, Johnson Cl, 2002).

i. Genetics

Body adiposity is influenced by the interaction of genotype and environment.
Data suggests that at least 40% of body mass is genetically determined (Bouchard C,
Perusse L, 1993). This has been examined in twin, adopted, and family studies
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(Lefebvre pJ, Scheen AJ, 2001). Based on a series of twin studies, Bouchard
ted that 25-40% of body weight regulation might be related to genetic factors
sugge S
(Bouchard C, 1994; Bouchard C, Tremblay A, Despres JP, Nadeau A, Dussault J,
Moorjani

s, Pinault S, Fournier G, 1990).

ii. Cultural/Socioeconmic
Data suggest that an inverse relationship exists between obesity and
socioeconomic status (Sobal J, Stunkard AJ, 1989). The reasons for this association
might be due to childhood experiences such as parental neglect (Lissau I, Sorensen
TIA, 1994) indigent residence (Lissau I, Sorensen TIA, 1994), and social isolation
(Kinra S, Nelder RP, Leweendon GJ, 2000). In addition, a relationship between
socioeconomic hierarchy and BMI has been observed. Data has shown that people of
higher socioeconomic status have a lower prevalence of obesity in part due to their
heightened interest in health and fitness (Wardl J, Griffith J, 2001). Other factors
involved include the higher financial expense to eat healthy including foods such as
fresh fruits and vegetables. Data sµggest that people of lower socioeconomic status
tend to purchase economical foods, which are most often higher in fat and calories
potentially leading to weight gain (Drewnowski A, 2003).
Cultural and ethnic factors have been associated with obesity. Minority groups
have had a higher increase in obesity as compared to Caucasians with the exception of
Asians (Drewnowski A, 2004). African American women have the highest prevalence
of obesity compared to other minority groups (Flegal Km, Carroll MD, Ogen CL,
Johnson Cl, 2002). The reasons for this disparity are still unclear; however, evidence
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. to physical inactivity (Weisner RL, Hunter GR, Heini AF, Goran MI, Sell SM,
paints
1998) as a primary factor as well as lifestyle, environment, genetics, race, and energy
metabolism (Lovejoy JC, Champagne CM, Smith SR, de Jonge L, Xie H, 2001).

iii. Psychological

According to the NHANES, depression is associated with an increased
prevalence of obesity in the US (DiPietro L, Anda RF, Williamson DF, Stunkard AJ,
1992). The psychological influences on the onset of obesity include both mental health
status and the use of psychotropic medications. These medications block the receptors
for neurotransmitters associated with weight regulation, such as serotonin, resulting in
potential weight gain (Devlin MJ, Yanovski SZ, Wilson GT, 2000). In addition,
people with depression often rely on eating to improve their mood resulting in weight
gain (Wurtman RJ, Wurtman JJ, 1998).

iv. Behavioral and Environmental (Diet and Physical Activity)

Positive energy balance is.the primary cause for increased adiposity (NIH,

NHLBI, 1998). Energy intake has increased over the past two decades most likely
from the increased consumption of meals away from the home, the availability of high
calorie snack foods and convenience foods, and an increase in portion sizes (Young

LR, Nestle M, 2002). These foods include high fat foods, added sugar in snacks (Zizza
C, Siega-Riz AM, Popkin BM, 2001), sugared beverages (Harnack L, Stang J, Story

M, 1999), and fast foods (French SA, Story M, Jeffery RW, 2001). WHO suggests that
high-energy dense foods such as fast foods have significantly contributed to the global
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. pidemic (WHO, 2003). This was supported in a secondary analysis of the
obesity e

cA.RDIA Study. Subjects who ate fast foods more than twice a week over 10 years
. d an extra 4.5 kilograms of body weight compared to those subjects consuming
game
fast foods less than one time per week (Pereira MA, Kartashov AI, Ebbeling CB, Van

Hom L, Slattery ML, Jacobs DR Jr, Ludwig DS, 2005).
Studies have shown a negative relationship between BMI and physical activity
(Gortmaker SL, Must A, Sobol AM, Peterson K, Colditz GA, Dietz WH, 1996). A
sedentary lifestyle promotes weight gain by decreasing energy expenditure. Data
suggest that inadequate physical activity is strongly associated with weight gain in

both genders. This was shown in a study lasting a decade and included adult subjects
between the ages of 25 and 7 4 years. Subjects who were inactive were more likely to
gain between three and four times more weight than the active subjects (Williamson

DF, Madans J, Anda RF, Kleinman JC, Kahn HS, Byers TJ, 1993). The sedentary
behavior most likely to promote weight gain is television viewing. The Nurses' Health
Study identified a 23% increase in obesity with frequent television watching (Hu FB,
Li TY, Colditz GA, Willett WC, 2003).

C. Non-Surgical Obesity Interventions
i. Diet

Non-surgical interventions for the treatment of obesity include four
modalities: diet, physical exercise, behavior modification, and medications (Mun EC,

Blackbum GL, Matthews JB, 2001). Dietary interventions include moderate calorie
restriction and very low calorie diets (VLCDs). VLCDs consist of an energy intake of
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200_800 kilocalories daily (Bray G, 1998). Individuals presenting with a BMI greater

than 30 kg/m 2 and have failed other weight loss approaches might be prescribed a
VLCD under close medical supervision. Although this approach promotes rapid initial
weight loss, long-term efficacy is lacking (Wadden TA, Foster GD, Letizia KA, 1994).
Moderate calorie restriction is more balanced in terms of nutrient content and consists
of a caloric deficit of 500-1000 kilocalories daily, promoting a weight loss of
approximately Yz-1 kilogram weekly.
A recent study by Dansinger and colleagues compared four commercial diets
(Weight Watchers, Omish, Atkins, and Zone) on dietary compliance along with
weight loss outcomes and CVD risk factor improvements. The 160 participants in this
study were randomized to one of the above commercial diets. They were advised to
follow these diets per dietary protocol for two months at which time participants were
able to adhere to the diets per self-selection. All measured outcomes at one year were
self-reported by participants. Those participants that completed the study had more
weight loss and improvements in CVD risk factors compared to those that did not
complete the study. All of the diets significantly improved participants' cholesterol
ratio; however, there were no differences in blood pressure and blood glucose at one

year. Participants with greater dietary compliance had more weight loss and
improvement in CVD risk factors. Among the four diets, total mean weight loss was at

one year was 2.1 to 3.3 kilograms indicating modest weight loss (Dansinger ML,
Gleason JA, Griffith JL, Selker HP, Schaefer EJ).
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ii. Exercise
Physical activity and exercise are important elements in successful weight loss
interventions. Some studies have reported limited or no weight loss implementing
physical activity and exercise without adjunct dietary therapy (Garrow JS, Summerbell
CD, 1995). However, interventions combining diet and exercise have been effective.

In regards to the health benefits from exercise, several studies have reported beneficial
health effects such as improvement of diabetes and cardiovascular disease (Tremblay

A, Despres JP, Maheux J, Pouliot MC, Nadeau A, Moorjani S, Lupien PJ, Bouchard
C, 1991; Ekelund LG, Haskell WL, Johnson JL, Whaley FS, Criqui MH, Sheps DS.
1988).

iii. Behavior Therapy
Behavior therapy seeks to identify the barriers preventing adherence to dietary
and physical activity interventions important for the promotion of weight reduction
and weight maintenance. This therapy has shown to be effective in conjunction with
diet therapy. In fact, long-term follow-up of patients has indicated weight regain
without behavior therapy (Wadden TA, Foster GD, Letizia KA, 1994). The
Identification, Evaluation and Treatment of Overweight and Obesity in Adults NIH
Expert Panel recommends that weight reduction and weight maintenance programs
consist of both dietary and behavior therapy for the promotion and maintenance of
Weight loss (NIH, 1998).
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. Pharmacotherapy

JV.

Phannacotherapy for the promotion of weight loss includes two primary
ased on their mode of action: appetite suppression and initiation of
classes b
thennogenesis and intestinal fat malabsorption or both. (Bray GA, 1993). Currently,
there are several weight loss medications in use: Orilstat, an inhibitor of pancreatic
lipase promoting malabsorption of dietary trigylcerides (Hauptman JB, Jeunet FS,
Hartman D, 1992); Sibutramine, an anorexiant (Rolls BJ, Shide DJ, Thorwart ML,
Ulbrecht JS, 1998); and Phentermine, an anorexiant (Bray GA, 1993). These
medications are most effective when prescribed in adjunct with diet therapy, behavior
therapy, and exercise (Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R,
Steinberg C, 2001). The efficacy of these medications is variable, most often
promoting a weight loss up to ten percent based on pre-treatment weight with an
expected regain of at least some of the weight lost. However, some studies suggest
that there is less weight regain in those subjects on pharmacotherapy for weight
reduction (Sjostrom L, Rissanen A, Andersen T, Boldrin M, Golay A, Koppeschaar
HP, KrempfM, 1998; James WP, _1995; Finer N, Bloom SR, Frost GS, Banks LM,
Griffiths J, 2000). Pharmacotherapy has not promoted significant weight loss for the
morbidly obese person, and therefore is not considered an efficacious treatment for
those with a BMI > 40 kg/m 2 .

D. Racial Disparities in Obesity and Health
There are clear ethnic differences in the prevalence of obesity. More than twothirds of African American women are considered overweight or obese which is 1.4

32

.
greater than Caucasian women (Linquist CH, Gower BA, Goran MI, 2000;
tunes
. er RL Hunter GR, Zuckerman PA, Redden DT, Darnell BE, Larson DE,
We1sn
'
Newcomer BR, Goran MI, 2000). The prevalence of obesity as reported by the
NJfANES 1999-2000 increased by 11.5 % and 7.2 % among African American and
Caucasian women, respectively, compared to NHANES III (Flegal Km, Carroll MD,
Ogen CL, Johnson Cl, 2002).

i. Comorbidities
Obesity has been shown to be a major risk factor in the development of several
comorbidities including CVD, diabetes, and certain cancers (Linquist CH, Gower BA,
Goran MI, 2000). Obesity in African Americans is associated with diabetes and
hypertension. African Americans have double the risk of developing CVD and type 2
diabetes compared to Caucasians (Harris MI, 1990). Complications associated with
type 2 diabetes; such as retinopathy, nephropathy, neuropathy, and lower extremity
amputations are greater in African Americans than Caucasians (Harris MI, 2001). Data
suggest that pre- and postmenopaD;sal African American women are more insulin
resistant than their Caucasian counterparts indicating an increased propensity to
developing type 2 diabetes (Ryan AS, Nicklas BJ, Beman DM, 2002). Gower et. al.
found that both premenopausal obese African American and Caucasian women
showed improvements in HDL cholesterol, total cholesterol, and LDL cholesterol with
weight loss (Gower BA, Weisner RL, Jordan JM, Hunter GR, Desmond R, 2002).
The North Carolina WISEWOMAN project showed that obese African American
women had higher body mass indices but did not show significant differences in the
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prevalen

ce of hypertension compared to their obese Caucasian counterparts. However,

se African American women had a significantly higher prevalence of

non-obe

hypertension than non-obese Caucasian women (Nelson TL, Hunt KJ, Rosamond WD,
.AmJllennan AS, Keyserling TC, Mokdad AH, Will JC, 2002). Weight differences
between African Americans and Caucasians appear in childhood, which might
contribute to the increased risk for diabetes and CVD seen in African Americans
(Straus RS, Pollack HA, 2000; Freedman DS, Srinivasan SR, Valdez RA, Williamson

OF, Berenson GS, 1997). Due to these racial disparities, it is important to target
weight loss and the prevention of dsease interventions toward ethnic needs.

ii. Metabolism
Ethnic differences in EE have been observed in several studies. Data suggest

that African Americans have a lower resting energy expenditure (REE) compared to
their Caucasian counterparts (Sharp TA, Bell ML, Grunwald GK, Schmitz KH, Sidney
S, Lewis CE, Tolan K, Hill JO, 2002). Gannon et. al. reviewed 15 studies examining
the effects of energy expenditure parameters on weight loss comparing African
Americans and Caucasians. Twelve studies found lower EE in African Americans
using indirect calorimetry and doubly labeled water methods. Two of the five
remaining studies found that African Americans have lower total daily energy
expenditure (TDEE) as a result of decreased physical activity energy expenditure
(PAEE) (Gannon B, DiPietro L, Poehlman ET, 2000). Hunter et. al. suggested that a
possible reason for this lower REE in African Americans might be from the decreased
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·cally active trunk (organ) tissue found in African Americans compared to
metaboli
·ans (Hunter GR, Weisner RL, Darnell BE, Zuckerman PA, Goran MI, 2000).
caucas1
Data suggest that muscle tissue type might have an effect on weight loss with
Type 1 fibers being more metabolically active compared to type Ilb muscle fibers
(Tanner CJ, Barakat HA, Lynis Dohrn G, Pories WJ, MacDonald KG, Cunningham

PRG, Swanson MS, Hournard JA, 2002). Tanner et.al. compared muscle fiber type
and weight loss outcomes between African American and Caucasian women. Subjects
were grouped and compared by ethnic background and BMI. Results showed that
obese African American women had a significantly higher number of type Ilb muscle
fibers compared to their Caucasian counterparts. Interestingly, this study found a
positive relationship between the amount of type 1 muscle fibers and the degree of
weight loss in the obese groups (Tanner CJ, Barakat HA, Lynis Dohrn G, Pories WJ,
MacDonald KG, Cunningham PRG, Swanson MS, Houmard JA, 2002).
Lovejoy et. al. examined the disparities in EE and dietary intake between
premenopausal middle-aged African American and Caucasian women participating in
the Parent, Healthly Transition Study. Dietary data was collected from food journals
completed by subjects for four days and analyzed using nutrient analysis computer
software. Using direct calorimetry, sleep energy expenditure (SEE) was lower in
African American women compared to Caucasian women. Intake of protein was
significantly lower in African American women than in their Caucasian counterparts.
However, no ethnic differences were found in fat and carbohydrate intake (Lovejoy
JC, Champagne CM, Smith SR, de Jong L, Xie H, 2001). The above findings suggest
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that ethnic differences in EE and protein intake might have an impact on the
lence of obesity in African American women.
preva
Foster et.al. compared the effects of weight loss in obese African American

(BMI 36.8 ± 4.4) and Caucasian (36.1±5.1) women. Subjects included non-smoking
women without significant medical or psychiatric disorders. Prior to the weight loss
intervention, REE was measured using indirect calorimetry and was shown to be
significantly lower in African American women than in Caucasian women. After
following equivalent dietary plans, African Americans lost 2.5% less weight than
Caucasian women. African American women had greater reductions in REE than
Caucasian women after the weight loss intervention suggesting that obese African
American women have increased efficiency in conserving body weight compared to
obese Caucasian women resulting from a greater decrease in REE (Foster GD,
Wadden TA, Swain RM, Anderson DA, Vogt RA, 1999).

II. Gastric Bypass Surgery (GBP) for the Treatment of Extreme Obesity
The Roux-en-Y gastric bypass procedure (RYGBP) was first introduced for the
treatment of morbid obesity in the late 1960's. Edward Mason, MD developed this
procedure based on the significant weight loss outcomes from patients following
partial gastrectomy surgeries (Mason EE, 1992). The RYGBP is now recognized as
the gold standard treatment for many patients with Class III obesity, especially those
with serious medical co-morbid conditions. Approximately 109,000 weight loss
surgeries are performed annually in the US (Klein S, Burke LE, Bray, George, Blair S,

All"
.
Ison DB, P1-Sunyer X, Hong Y, Eckel RH, 2004). This procedure has demonstrated
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·nable weight loss with manageable complications both in the short- and longsustai

tenn (S

chauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J, 2000).
The RYGBP is achieved by creating approximately a 30 mL pouch in the

proximal stomach. The gastric pouch is divided from the remaining distal stomach by
staples. The transit of food passes from the pouch through a tight outlet or stoma into
the jejunum while bypassing the duodenum. The small pouch and narrow outlet result
in restricted calorie intake. Weight loss results primarily from the small pouch
capacity leading to early satiety and decreased energy intake (Sonnanstine TE, Kim JJ,
Shikora SA, 2004).
Bariatric surgeries have proven to be efficacious for long-term weight loss,
with the RYGBP yielding the greatest benefit with fewer complications (NIH
Conference Development Conference Panel, 1991). These surgeries predispose
patients to maldigestion and malabsorption due to the anatomical changes of the
stomach and small bowel, and the potential for inappropriate dietary and eating
behaviors. It is critical that patients fully comprehend the dietary and eating behavior
restrictions following bariatric surgery necessitating comprehensive preoperative
nutrition education and behavior modification counseling.
The postoperative care ofbariatric surgery patients should include a
multidisciplinary approach. The dietitian plays a primary role in this team approach, in
the prevention and treatment of disordered eating behaviors and nutritional
deficiencies. Patients with preoperative active eating disorders are not considered
candidates for bariatric surgery, unless they undergo treatment with documented
resolution of this behavior prior to surgery. However, disordered eating behavior
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might develop postoperatively, requiring judicious monitoring by the bariatric team
(Betsy Lehman Center Expert Panel, 2004). Nutrition support following bariatric
surgery

aims to promote adequate nutrition and hydration to ensure homeostatic

support of bodily functions, promote wound healing, and spare lean body mass. The
post-bariatric surgery diet should be advanced in stages to achieve adequate nutrition
support and food tolerance (Elliot K, 2003). The following review will delineate the
primary nutritional considerations following bariatric surgeries including short- and
long-term medical nutrition therapy.

A. Energy and Macronutrient Needs
i. Energy

Insufficient data is available to provide evidence-based recommendations for
daily calorie, protein, carbohydrate, and fat intake following bariatric surgery. Caloric
intake during the first few months postoperatively might be fewer than 1000
kilocalories daily with a moderate increase during the first year (Moize V, Geliebter
A, Gluck ME, Yahav E, Lorence E, Colarusso T, Drake V, Flancbaum L, 2003;
Kenler HA, Brolin RE, Cody RP, .1990; Coughlin K, Bell RM, Bivins BA, Wrobel S,
Griffen WO Jr, 1983; Betsy Lehman Center Expert Panel, 2004). As dietary intake
increases after surgery, energy provided varies with the volume of food and fluid that
is tolerated. Daily caloric intake usually approaches 400 calories for the first four
weeks postoperatively. Intake can be expected to increase to 800-1000 kilocalories
daily by the end of the third postoperative month, with weight loss being most rapid
during this time period (Betsy Lehman Center Expert Panel, 2004).
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Greater than 25% of the total daily calories should come from high quality
·n (60-80 grams daily). Fat intake should be approximately 25-30 % of the total
prote1
daily kilocalories. As carbohydrate is protein sparing, approximately 40-50 % of the
remaining energy should be supplied as carbohydrate with at least 100 grams per day
being recommended for the prevention of ketosis (Betsy Lehman Center Expert Panel,
2004).

ii. Protein

Protein-calorie malnutrition is uncommon in patients who have had gastric
restrictive surgeries such as the RYGBP and vertical banded gastroplasty (VBG)
unless an anatomical problem such as stomal stenosis is present leading to poor dietary
intake (Bryne KT, 2001). Adequate protein intake is encouraged postoperatively for
improved healing and to maintain adequate visceral protein stores as well as to
decrease loss of lean body mass. Due to the small capacity of the gastric pouch
following restrictive surgeries, an increased intolerance to meats might occur. Modular
and liquid protein supplements 1,11ight be necessary to promote adequate daily protein
intake. The recommendations for protein intake as indicated by the Betsy Lehman
Center Weight Loss Surgery Expert Panel are 1-1.5 g/kg ideal body weight (IBW)
daily (Betsy Lehman Center Expert Panel, 2004). Some programs use adjusted body
weight (ABW) rather than IBW to estimate macronutrient needs. High biological
value protein sources such as meats (i.e. chicken, fish) and dairy (i.e. milk, cheese) are
encouraged to ensure intake of all essential amino acids for the promotion of wound
healing.
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As patients become more weight stable, adequate protein intake continues to
uraged for the preservation and restoration of lean body mass and increased
be encO

. t As is widely accepted, adequate energy intake is required for positive nitrogen

sane Y·

balance. It has been noted that protein intake and absorption are compromised due to
gastric restriction and intestinal bypass. Decreased availability of pepsin, rennin, and
hydrochloric acid might inhibit optimal protein digestion with subsequent intolerances
(Moize V, Geliebter A, Gluck ME, Yahav E, Lorence M, Colarusso T, Drake V,
Flancbaum L, 2003).
Protein malnutrition, particularly the hypoalbuminemic form, is of greatest
concern following highly malabsorptive surgeries. Postoperative protein requirements
have been estimated at 90 grams per day from high biological value sources
(Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverso E, Friedman D,
Camerini G, Baschieri G, Simonelli A, 1998).

iii. Carbohydrate

Carbohydrate intake is increased gradually postoperatively. Patients should be
educated on the types and amounts of carbohydrate to consume using resources such
as the ADA Exchange System (ADA, 1995). Due to limited evidence-based data on
macronutrient needs following bariatric surgery, recommendations are usually based
on the Dietary Reference Intakes (DRis) of 2002 (IOM, 2002) and modified to
individual need. A minimum of 100 grams of carbohydrate per day is recommended to
prevent ketosis following the second postoperative month (Betsy Lehman Center
Expert Panel, 2004).
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Nutrition education focusing on reading food labels is useful to help patients
'd fioods containing large amounts of sugar. Consumption of such foods might lead

aVOl

to the rapid gastric emptying, diarrhea and gastrointestinal discomfort associated with
dumping syndrome, discussed in greater detail later in this review. Patients should
choose foods with less than seven grams of sugar per 100-kilocalorie serving.
Furthennore, patients should be counseled on avoiding foods containing elevated
levels of sugar alcohols due to their laxative effect (Betsy Lehman Center Expert
Panel, 2004).

iv. Fat
The recommendations for fat intake usually change following most bariatric
surgeries. Significant decreases in dietary intake usually occur up to one year
postoperatively as a result of gastric restriction, potential food intolerances, and
anatomic anomalies. After the first year, fat and carbohydrate intake usually increase
while protein intake decreases, as patients begin to tolerate a greater variety of foods.
Those patients who maintain higher protein intake and lower fat intake tend to
consume fewer calories rendering a better weight loss. This suggests that weight loss
efficiency following bariatric surgery might be, in part, associated with a decreased
percentage of total energy from fat. Based on these results, dietary recommendations
following bariatric surgery should not only focus on total energy intake but also on the
distribution of calories from protein, carbohydrate, and fat. (Coughlin K, Bell RM,
Bivins BA, Wrobel S, Griffen WO Jr., 1983).
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Literature suggests that no more than 25% of total calories should come from

fat for a healthy diet following bariatric surgery to promote better weight loss and
weight maintenance (Mallory G, 1992). Small amounts of fat (10 grams) at each meal
should be encouraged which will assist with maintaining gallbladder emptying and
minimizing the risk of cholelithiasis, especially during rapid weight loss (Betsy
Lehman Center Expert Panel, 2004). This is also recommended in patients who have
had a cholecystectomy, to limit symptoms associated with fat malabsorption.
In order to provide a more balanced diet, adequate carbohydrate and fat are
recommended with an emphasis on protein intake (Kenler HA, Brohn RE, Cody RP,
1990). However, insufficient data is available to provide specific evidence-based
recommendations for energy and macronutrient intake. It is prudent that future
research focus on the long-term nutritional needs following bariatric surgeries to help
prevent weight recidivism and nutritional deficiencies.

B. Micronutrient Considerations
Micronutrient deficiencies might occur in all weight loss surgery patients
regardless of procedure. This is due to reduction in overall food intake and decreased
consumption of specific foods or classes of foods such as dairy and red meat. Because
of the limited quantity of food consumed, nutrition support is focused on maximizing
the quality of these foods (Collene AL, Hertzler SH, 2003). Bariatric surgeries,
especially malabsorptive procedures, compromise micronutrient absorption as a result
of the relatively low-acid environment of the gastric pouch, impaired binding to carrier
proteins, insufficient capacity to liberate food-bound micronutrients, and decreased
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abso rp

tive surfaces of the small bowel. For these reasons, weight loss surgery patients

·sk for several deficiencies including vitamin B 12 , folic acid, vitamin D and
are at n
other fat-soluble vitamins, calcium, and iron (Elliot K, 2003; Betsy Lehman Center
Expert Panel, 2004). All preoperative bariatric patients should undergo assessment of
micronutrient status with repletion of any deficiencies. Since obesity is generally
associated with normal or supranormal bone mineral density, routine preoperative
bone density assessment does not appear to be needed; however, assessment might be
advisable for post-menopausal women or others at high risk for osteoporosis. The
following pages will discuss the primary micronutrient deficiencies with guidelines for
prevention and treatment. (Betsy Lehman Center Expert Panel, 2004).

i. Iron
Iron is a trace mineral that is involved in oxidation and reduction activities
involved in cellular respiration. Iron plays a primary role in red blood cell function,
myoglobin activity, and the utilization of multiple heme and nonheme enzymes
(Mahan K, Escott-Stump S, 2000). The average adult stores approximately one to
three grams of iron with a depletion of about one milligram daily, primarily through
the shedding of cells from the skin and lining of the intestinal mucosa. However,
menstruating women lose an average of two milligrams daily, increasing their risk for
iron-deficiency anemia (Betsy Lehman Center Expert Panel, 2004).
Bariatric surgeries that alter the gut physiology and bypass portions of the
small intestine compromise digestion and absorption of iron leading to possible iron
deficiency. Iron absorption occurs in the duodenum and proximal jejunum, which are
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bypas

sed in the RYGBP and other malabsorptive procedures. Iron requires gastric

.d primarily hydrochloric acid of the stomach, for conversion to its soluble form.

ac1 '

Following gastric restrictive intestinal bypass surgeries, both the acid environment of
the stomach and available mucosal surface of the small intestine are altered increasing
the risk for iron deficiency with or without anemia (Kushner R, 2000; Elliot K, 2003).
Due to the small size of the gastric pouch and decreased acid production, many
patients have difficulty tolerating meats containing heme iron, the most bioavailable

form (Moize V, Geliebter A, Gluck ME, Yahav E, Lorence M, Colarusso T, Drake V,
Flancbaum L., 2003)
Iron and ferritin should be measured and deficiencies corrected pre- and
postoperatively for the prevention of iron deficiency and subsequent anemias. Serum
iron levels tend to decline within the first year after surgery. Supplementation is
recommended with a downward trend in serum iron levels to prevent the onset of irondeficiency anemia (Brohn RE, Gorman RC, Milgrim LM, Kenler HA, 1991). Due to
declining iron storage over the long-term, lifelong monitoring is recommended.
Patients presenting with iron deficiency should be instructed to take oral iron
supplementation within a range of 180-220 milligrams of elemental iron daily for
repletion of iron stores (Brohn RE, Gorman JH, Gorman RC, Petschenik AJ, Bradley

LB, Keuler HA, Cody RP, 1998). Menstruating women should receive 40-65
milligrams of elemental iron prophylactically after gastric restrictive and intestinal
bypass surgery. Iron sources such as ferrous sulfate, gluconate, or fumarate are usually
recommended daily along with approximately 500 milligrams of vitamin C (Kushner

R, 2000). Vitamin C enhances iron absorption due to its role in the conversion from
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the ferric to the absorbable ferrous form. Iron supplements containing vitamin C are
ideal for patients to prevent having to take additional supplements (Betsy Lehman
Center Expert Panel, 2004).

ii. Vitamin Bl 2
The primary function of vitamin B 12 is to promote normal metabolism of cells,
primarily from the nervous system, gastrointestinal tract, and bone marrow (Mahan K,
Escott-Stump S, 2000). Vitamin B12 deficiency is common following gastric
restrictive intestinal bypass surgery.
Contributing factors to vitamin B12 deficiency include food restriction and
reduced gastric hydrochloric acid, pepsin, and pancreatic enzymes leading to impaired
release of protein-bound vitamin B12 from foods. Vitamin B12 deficiency might be,
in part, a result of impaired secretion of intrinsic factor, impaired binding capacity of
intrinsic factor with vitamin B12, and bacterial overgrowth as a result ofreduced
motility of the bypassed small intestine (Collene AL, Hertzler SH, 2003). The onset of
this deficiency is usually after the .first postoperative year because of enterohepatic
recycling of vitamin B12 and the release of hepatic stores (Collene AL, Hertzler SH,
2003). Serum vitamin B 12 levels will deplete rapidly without daily multivitamin
supplementation and adequate dietary intake of vitamin B 12. Patients should be
counseled on increasing dietary sources of vitamin B12 such as dairy, meat, and eggs.
Supplementation with crystalline vitamin B 12 found in multivitamins might prevent
deficiency in some patients, and should be prescribed for all postoperative patients not
identified as deficient. Vitamin B12 supplementation should be initiated in patients
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prese

nting with suboptimal serum vitamin B12 levels. Oral vitamin B12

supPl

ementation of at least 350 micrograms per day is usually adequate; however,

with severe deficiency, intramuscular vitamin B 12 is recommended (Elliot K, 2003;
Betsy Lehman Center Expert Panel, 2004).

iii. Folate
Folate, a B vitamin, is a coenzyme involved in the metabolism of nucleotides
and amino acids (Mahan K, Escott-Stump S, 2000), and plays a primary role in the
prevention of megaloblastic anemia. The jejunum is the primary site of folate
absorption; however, some absorption occurs throughout the small bowel (Hunt SM,
Groff JG, 1990). Approximately 20% of patients develop folate deficiency following
gastric restrictive intestinal bypass surgery. Bacterial production of folate in the
proximal large bowel might compensate for some of the decreased folate absorption
(Collene AL, Hertzler SH, 2003; Kumpf VJ, 1996). Intake of high folate-containing
food sources such as fortified grains and dark green leafy vegetables should be
encouraged, when these foods are .reintroduced into the diet. Prevention of deficiency
can usually be achieved with daily multivitamin supplementation containing 200-400
micrograms of folate (Betsy Lehman Center Expert Panel, 2004).

iv. Thiamin
Thiamin deficiency is rare but has been reported following gastric restrictive
intestinal bypass surgery (Deitel M, Cowan G, 2000). Thiamin plays an important role
In energy transformation

and neural function. Primary absorption occurs in the
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. . um but thiamin can also be absorbed throughout the small intestine. Excessive
JeJUn '
vomiting, malnutrition and alcoholism are contributors to thiamin deficiency,
potentially resulting in cranial nerve palsy, peripheral neuropathies, and the
encephalopathy associated with Wemicke-Korsakoff syndrome (Mahan K, EscottStump S, 2000). As with folate, deficiency of this B vitamin is most often prevented
by daily multivitamin supplementation. Oral thiamin supplementation of
approximately ten milligrams daily is usually effective in correcting mild deficiency;
however, severe deficiencies require intravenous infusion of 100 milligrams for seven
to 14 days followed by ten milligrams daily until symptoms resolve (Kushner R,

2000). All patients should be monitored for thiamin deficiency, as patients without
preoperative risk factors or concurrent alcohol abuse are at risk for deficiencies.

vi. Calcium
Calcium is a mineral essential for the health of bones and teeth, clotting of
blood, hormone secretion and nerve function, and cardiac and skeletal muscle
contraction (Hunt SM, Groff JG, 1990). Calcium absorption and utilization is affected
by many factors. Reduced exposure to sunlight and diets high in oxalates found in
some leafy green vegetables might result in compromised calcium absorption. Diets
high in fat, protein, alcohol, and high doses of vitamin A decrease the bioavailability
of dietary calcium. Caffeine and sodium, in large quantities, might increase urinary
excretion of calcium (Charles P, 2003).
Patients undergoing weight loss surgeries are at increased risk for developing
calcium deficiencies, potentially leading to metabolic bone disease. Contributing
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'nclude: decreased consumption of foods containing calcium and vitamin D;
factor S l
bypassing the duodenum and proximal jejunum, the primary sites for calcium
absorption via active transport; and malabsorption of vitamin D (Elliot, 2003).
Most obese patients have a decreased risk for osteoporosis; however, bone
mineral density tends to lessen with weight loss, and is usually proportional to the rate
and degree of weight loss and dietary intake of calcium (Goode LR, Brolin RE,
Chowdhury HA, Shapses SE, 2004; Brano G, Rodin DA, Pazianas M, Nussey SS,
1999). Gastric secretions are more acidic prior to surgery, facilitating optimal calcium
absorption. Following gastric restrictive surgery, the acidic environment lessens due to
the decreased volume of the gastric pouch, resulting in impaired calcium absorption.
Calcium absorption can occur throughout the bowel via passive diffusion; however,
the amount of dietary calcium must increase above the recommended allowances to
achieve adequate absorption (Kushner R, 2000).
Calcium deficiency is more difficult to detect than vitamin and iron
deficiencies. Serum levels are not indicative of calcium status, as multiple
mechanisms, such as bone demin.eralization, exist to maintain serum calcium (Collene,

AL, Hertzler, SH, 2003 ; Kushner, R, 2000). Serum calcium is bound to albumin and
is found free-floating as ionized calcium. Calcium levels might be falsely depleted if
serum protein levels are low. It is prudent to obtain ionized calcium levels in these
circumstances (Kushner R, 2000).
Markers for metabolic bone disease have been observed as early as three
months after surgery, and include increased alkaline phosphatase levels, reduced
serum calcium levels, and decreased 25 (OH) vitamin D levels (Coates PS, Fernstrom
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D Fernstrom MH, Schauer PR, Greenspan SL, 2004). Hypocalcemia occurs more
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frequently with procedures inducing a greater degree of malabsorption. Serum
calcium, phosphorus, alkaline phosphatase and 25 (OH) vitamin D levels should be
periodically monitored postoperatively. Long-term consequences of altered calcium
metabolism have not been well defined (Coates PS, Fernstrom JD, Fernstrom MH,
Schauer PR, Greenspan SL, 2004). More research is needed to establish conclusive
evidence with regard to bone health.
As a result of the potential for metabolic bone disease, the literature suggests
lifelong daily supplementation of 1200-1500 milligrams of calcium citrate with
vitamin D in divided doses, as calcium citrate is the most soluble form in the absence
of gastric acid production (Kushner R, 2000). Supplemental calcium absorption is
most often increased when taken with meals. However, as parathyroid hormonestimulated bone resorption is decreased nocturnally, calcium supplements may be
taken at bedtime without regard to food (Charles P, 2003). Calcium and iron tend to
compete for absorption, and therefore should be taken at least one hour apart.

vi. Vitamin D
Vitamin D is essential for the regulation of normal serum calcium levels and
bone health. It is rapidly absorbed in the duodenum, but a greater amount is absorbed
in the ileum with the aid of pancreatic and biliary secretions. Due to the bypassing of
the duodenum and upper jejunum in gastric restrictive intestinal bypass surgeries,
these secretions have less contact with food leading to malabsorption of vitamin D
(Hunt, SM, Groff JG, 1990; Collene, AL, Hertzler SH, 2003). This is not seen in
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restrictive bariatric surgeries. However, due to the decreased volume capacity of the
gastric pouch and variable tolerances to milk-based products, dietary intake is usually
not adequate. Compliance with taking multivitamins and calcium with vitamin D,
providing approximately 800 International Units (IUs) protects against this deficiency
(Dietel M, Cowan G, 2000). Supplementation for vitamin D deficiency ranges from
10,000-50,000 IUs weekly, tapering as indicated by laboratory indices. In highly
malabsorptive surgeries, vitamin D supplementation of 400,000 IUs intramuscularly
per month is recommended (Scopinaro N, Adami GF, Marinari GM, Gianetta E,
Traverso E, Friedman D, Camerini G, Baschieri G, Simonelli A, 1998).

C. Hydration
Hydration guidelines are not well documented in the literature for bariatric
surgeries. Hydration requirements are most often estimated by energy expenditure,
age, and body weight. As an estimated 25-50% of excess weight is metabolically
active tissue, it is prudent to use ABW when calculating daily fluid requirements as
follows: (ABW =[actual+ (actual-ideal)/4 (or 2 for 50%)]). Generally, an estimate of

50% is used for those patients presenting with a BMI greater than 50 kg/m2 (The
Science and Practice of Nutrition Support: A Case-Based Core Curriculum, 2001;
Marotta RB, 1991).
Dehydration is commonly seen after gastric restrictive intestinal bypass
surgeries. Obese patients require greater amounts of fluid than their non-obese
counterparts to maintain normal fluid balance and homeostasis (Kim JJ, Tarnoff ME,
Shikora SA, 2003). It is recommended that patients drink no more than eight fluid
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ounces of water per hour, at least during the first two months following bariatric
surgery due to increased swelling of the gastric pouch. While on soft solid food,
patients should wait approximately 30 minutes before and after eating three ounces or
one cup of solid food to consume fluids. After beginning a low fat diet consisting of
added fruits, vegetables, and starches, patients should wait approximately one hour
after meals to drink fluids. Following this fluid intake schedule helps to prevent
dumping syndrome and vomiting. Non-compliance usually leads to subsequent
grazing between meals due to increased hunger (Elliot K, 2003) with decreased weight
loss. It is imperative that clinicians promote and monitor for adequate hydration.
Following gastric restrictive procedures, consumption of carbonated beverages
tend to result in gastric sequelae (Elliot K, 2003) such as cramping, bloating, nausea,
and vomiting. It is recommended that patients abstain from the consumption of
carbonated beverages, especially during the first six postoperative months. Caffeinated
beverages such as coffee and tea should be avoided in the short-term following most
procedures, especially restrictive procedures, due to the potential for increased gastric
acid secretion with resulting gastr.oesophageal reflux (Boekema PJ, Samsom M,
Smout AJ, 1999). Caffeine also induces increased urine output , which can increase
risk for dehydration, particularly during rapid weight loss. Caffeinated beverages in
moderation may be resumed if hydration is adequate, and the risk for dehydration
minimal, as determined by laboratory indices and symptomatology (Betsy Lehman
Center Expert Panel, 2004).
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D. Dietary Advancement and Eating Behaviors Following Bariatric Surgery
The importance of thorough nutrition education for bariatric surgery patients
cannot be overstated. Evidence-based guidelines for dietary advancement have not
been established for all of the bariatric procedures currently in use. Recommendations
for dietary advancement following bariatric surgery have been compiled based on
post-gastrectomy nutritional guidelines. Close monitoring of dietary advancement and
tolerance by a bariatric dietitian is recommended to avoid potential complications
(Betsy Lehman Center Expert Panel, 2004).
Short-term postoperative nutritional considerations include adequate intake of
protein and fluid and the prevention of vomiting and dumping syndrome. Dumping
syndrome is characterized by rapid emptying of food into the jejunum increasing the
osmolarity of intestinal contents with a subsequent influx of fluid into the small
intestine. It is most common in the early postoperative period and becomes less
prominent after the first postoperative year (Collene AL, Hertzler SH, 2003). There is
great individual variability in the degree and severity of symptoms. This syndrome is
most often precipitated by ingestion of food and beverages with high sugar content,
and is prominent in gastric restrictive malabsorptive procedures such as the RYGBP.
To avoid symptoms, patients should be instructed to avoid juices, soda, and other high
sugar-containing beverages (Collene AL, Hertzler SH, 2003; Elliot K, 2003). Sensitive
individuals should avoid large doses of sugar alcohols; less than five grams per
serving can be used as a guideline to avoid a laxative effect (Betsy Lehman Center
Expert Panel, 2004).
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Several stages of dumping syndrome have been observed. The first stage
occurs within ten to 20 minutes after eating and usually involves abdominal bloating,
tachycardia, diaphoresis, flushing, and lightheadedness. The intermediate stage occurs
approximately 20 to more than 60 minutes following a meal and presents as abdominal
bloating, cramping, flatulence, and diarrhea. Finally, late stage dumping occurs oneto-three hours following a meal and is more often a consequence of reactive or
alimentary hypoglycemia. Symptoms of this stage most often include diaphoresis,
nervousness, lethargy, shakiness, decreased concentration, and increased hunger
(Mahan K, Escott-Stump S, 2000). Following gastric restrictive intestinal bypass
surgeries, food and liquid intake is minimized due to the small size of the gastric
pouch. Immediately postoperatively, the pouch has a capacity of approximately two
ounces, but can increase anywhere from two and a half to nine ounces over time
(Flanagan L, 1996). Due to the small pouch size, it is important for the patient and
dietitian to focus on incorporating high-quality, nutrient-dense foods. Fluid and
protein goals must be established in achievable, realistic amounts based on the reduced
gastric capacity and early satiety of the bariatric surgery patient.
The bariatric surgery diet progresses in a series of stages beginning with
liquids and progressively increases in texture. There is great variation among
programs in the rate of diet advancement due, in large part, to individual differences in
tolerance and readiness to advance (Elliot K, 2003; Marcasan W, 2004). The standard
postoperative diet consists of five to six stages, progressing over a two-month period.
In the immediate postoperative period, patients consume no food or fluid by
mouth for approximately 24 hours, and are supported with intravenous solutions of
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saline or lactated ringers to provide adequate hydration. It is recommended
dex: trOse '
that this therapy be continued until patients tolerate a full liquid diet for a minimum of
24 hours. Amino acid/saline intravenous solutions are sometimes provided; however,
there is no literature indicating this therapy will result in preservation of visceral
protein given the small amount of calories provided and the short duration of the
therapy (Betsy Lehman Center Expert Panel, 2004).
Stage I of the diet is initiated approximately 24 hours after surgery, and
consists of 30 mL per hour of water for a 24-hour period. If tolerated, patients are
advanced to Stage II, consisting of no-added sugar clear liquids for another 24 hours.
No-added sugar full liquids are provided in Stage III, for another 24 hours. In the
absence of complications, patients are normally discharged after 24 hours on a Stage
III diet. Postoperative outpatient follow up visits are scheduled with both the surgeon
and the dietitian. At this time patients are instructed to begin the Stage IV high-protein
soft-solid diet three weeks after surgery, as tolerated. Patients remain on the Stage IV
diet for approximately one month. Advancement to the Stage V low-fat solid diet
occurs, when the patient demonstrates tolerance to soft solids. Patients continue on the
low-fat diet indefinitely with modifications made as needed (Betsy Lehman Center
Expert Panel, 2004).
Although not well documented in the scientific literature, there appear to be
common food intolerances. Typically, patients have difficulty tolerating milk, red
meat, dry or tough poultry or pork, bread or doughy starches, and vegetables high in
insoluble fiber (Collene AL, Hertzler SH, 2003). Over time, tolerance to these foods
often improves. Tolerance to diet advancement is facilitated by eating slowly, chewing
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foods thoroughly, avoiding tough-textured meats, and drinking a minimum of 30
minutes before or after meals. Postoperative vomiting is often subsequent to
inappropriate eating behaviors. However, vomiting can also be sign of an anatomical
problem such as an anastomatic stricture or stenosis, which should be ruled out if
vomiting persists. Intractable vomiting can potentially lead to serious nutritional
sequalae such as protein energy malnutrition (PEM) and thiamin deficiency. PEM is
rnore likely to occur in highly malabsorptive procedures such as biliopancreatic
diversion (BPD) (Marcason W, 2004; Knol, JA, 1994). Appendix B illustrates a series
of basic recommendations for each stage of the diet following most bariatric surgeries.
There is a need for long-term studies to determine the macro- and micronutrient requirements for patients following bariatric surgery for weight loss. Current
recommendations are based on requirements for weight loss, and specific
complications that arise from the various similar surgical procedures as highlighted
earlier in this review. Dietitians play an important role as a member of the medical
team to help prevent nutrient deficiencies, and maximize nutritional intake for
improved tolerance while preserving the desired rate of weight loss. Familiarity with
potential complications of each procedure can help the dietitian and patient prevent
and, if necessary, treat any feeding difficulties.

E. Restrictive Surgeries: An Overview
General nutrition recommendations for restrictive surgeries are largely
mechanical in nature. Patients are encouraged to consume small amounts of food, with
some variability depending on the size of the pouch created. Typically, one cup of
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food is well tolerated at each sitting. To prevent macro- and micronutrient
deficiencies, small, frequent meals containing nutrient-dense foods are recommended.
Patients are encouraged to chew food thoroughly, until the bolus is nearly liquefied,
prior to swallowing. This will aid in digestion, and help to allow the food to pass
through the small outlet from the stomach into the small intestine. Generally,
micronutrient deficiencies are uncommon, as absorptive capacity is unchanged. If
patients are unable to consume adequate calories to provide the recommended daily
intake ofmicronutrients supplementation should be considered (MacDonald KG Jr,

2001).
Nausea, vomiting, bloating, and reflux are some of the complications that
might result from inadequate chewing, and consuming portions of food that are too
large for the pouch size created. These complications might compromise the integrity
of the staple line, and contribute to band erosion in gastric band procedures
(Sonnanstine TE, Kim JJ, Shikora SA, 2004). Record keeping is useful to help patients
identify types and quantities of food, which might cause discomfort, distress, or
intolerance. As with any bariatric sµrgery, patients are encouraged to avoid highcalorie liquids and concentrated sweets, which might slow the rate of weight loss, or
even result in weight gain and displace nutrient-dense foods (Kenler HA, Brohn RE,
Cody RP, 1990).
Postoperative onset of disordered eating can occur as a result of induced
vomiting to relieve discomfort after overeating. Binge eating behavior can decrease
the integrity of the gastric pouch, and increase the volume capacity, which allows for
mcreased calorie ingestion with decreased weight loss efficiency. To avoid
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discomfort, patients tend to consume soft, high-calorie foods and liquids such as ice
eream '

creamed soups, and juices. Increased gastric volume can lead to outlet

obstruction, symptoms of which include vomiting and gastroesophageal reflux
(MacDonald KG Jr, 2001).

F. Combination Surgeries: An Overview

i. Biliopancreatic Diversion (BPD) with and without Duodenal Switch
BPD combines partial gastrectomy with intestinal bypass, with the greatest
impact of weight loss resulting from malabsorption. While the weight loss is greater
than that seen in RYGBP, the surgery carries an increased risk oflong-term nutritional
complications. It has been postulated that modification of the length of the bypassed
intestinal limb might allow for desired weight loss, while minimizing malabsorptive
complications (Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverso E,
Friedman D, Camerini G, Baschieri G, Simonelli A, 1998).
For up to one year postoperatively, dietary recommendations are similar to
those described earlier in this review. Patients may return to preoperative eating habits
within one year after BPD surgery without discomfort or impact on weight loss, due to
the effect of intestinal adaptation (Scopinaro N, Adami GF, Marinari GM, Gianetta E,
Traverso E, Friedman D, Camerini G, Baschieri G, Simonelli A, 1998). Fewer side
effects have been demonstrated with the duodenal switch procedure, although the
incidence of the most troublesome side effects of abdominal bloating and malodorous
stool was relatively unchanged. The degree of micronutrient deficiency appears to be
decreased with the duodenal switch approach, but it is recommended that patients be
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monitored for these deficiencies (Marceau P, Hould FS, Simard S, Lebel S, Bourque

RA, Potvin M, Biron S, 1998).
G. Special Considerations
i. Nutrition Support

Nutrition support guidelines following gastric restrictive intestinal bypass
surgeries generally are the same as for the postoperative gastrointestinal surgery
patient. Enteral nutrition may be utilized if a gastrostomy feeding tube was placed
during the bariatric procedure. If enteral access is not available, and the patient is
expected to be NPO more than seven days, total parenteral nutrition (TPN) may be
initiated. Contraindications to TPN are usually the same as for gastrointestinal surgery
patients in the presence of critical illness and sepsis. Bariatric surgery patients might
be at risk for refeeding syndrome if they have been NPO or on clear liquids for as few
as 48 hours prior to initiation of nutrition support. Judicious monitoring of electrolytes
and fluid balance is recommended while advancing nutrition support. Guidelines for
advancement have been established by the American Society for Parenteral and
Enteral Nutrition (ASPEN) and others, and are appropriate for the bariatric surgery
patient as well (The Science and Practice ofNutrition Support, 2001).

ii. Pregnancy

Pregnancy following weight loss surgery is considered high risk and should be
postponed for at least one year or until patients have reached a stable weight and
nutritional status. Pre-pregnancy assessment and planning is prudent to identify and
ameliorate micronutrient deficiencies prior to pregnancy. Prenatal vitamins are
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recommended in addition to prescribed vitamin and mineral supplementation as
preparation for pregnancy, and should continue throughout pregnancy (Wittgrove A,
l998; Preziosi P, 1997).
Iron requirements for women are greater in pregnancy and vary with each
trimester. During the first trimester, iron needs are reduced as a result of amenorrhea.
However, during the second trimester, as the plasma volume and red blood cell mass
increases close to 50% and 40%, respectively, iron needs also increase. Bariatric
surgery resulting in decreased intake of iron-containing foods due to intolerance and
altered digestion and absorption require prudent monitoring during pregnancy to
prevent the onset of iron-deficiency anemia. If patients present with iron deficiency
with or without anemia, iron supplementation should be initiated. Ferrous fumerate is
often tolerated and absorbed better by most patients following surgery (Wittgrove A,
1998).
To prevent the onset of iron deficiency, women should exhibit iron stores of
more than 300 milligrams prior to pregnancy. Iron supplementation of 30 milligrams
daily during the second trimester is recommended. However, 60 milligrams is
recommended for women presenting with a pre-pregnancy iron deficiency. Iron
supplements should be taken between meals to decrease gastric irritation and to
increase absorption (Bothwell TH, 2000).

H. Efficacy of Gastric Bypass Surgery
The RYGBP results in a weight loss of 65-80% of excess body weight at 1-1.5
years and 50-60% at five years after surgery. Given the efficacy of weight loss,
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bariatric surgeries including the RYGBP are considered the most effective
interventions for morbid obesity. Outcomes of the gastric bypass procedure not only
include effective weight loss but also improve obesity comorbidities (Stocker DJ,
2003).
i. Weight Reduction

The negative impact of obesity on the morbidity and mortality rates in the US
cannot be ignored. Conservative approaches to promote weight loss have shown to be
ineffective. Many traditional diets have promoted weight loss and subsequent
recidivism. GBP improves both weight loss rates and degree of weight loss along with
subsequent improvements in cardiovascular and metabolic sequelae (Schauer PR,
Ikramuddin S, Gourash W, Ramanathan R, Luketich J, 2000). In a small number of
clinical studies, it was reported that morbidly obese African American women lose
weight less efficiently and show less improvement in blood pressure than their
Caucasian counterparts following GBP (Schauer PR, Ikramuddin S, Gourash W,
Ramanathan R, Luketich J, 2000).
GBP has been shown to promote a 66% loss of excess weight in patients one to
two years following surgery, 60% at five years, and 50% at ten years (Sugerman HJ,
2001). Sugerman et.al. showed that African American patients lost less weight
compared to Caucasian patients following the laparoscopic adjustable silicone gastric
handing. The African American patients lost 11.5% ± 18% of their excess weight in
contrast to Caucasians losing 44% ± 26% at two years following GBP (DeMaria EJ,
Sugennan HJ, Meador JG, Doty JM, Kellum JM, Wolfe L, Szucs RA, Turner M,
2001 ). These racial disparities are important to acknowledge for targeting
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postoperative medical nutrition therapy to the needs of each ethnic group. This should
promote better weight loss and long-term weight maintenance.

ii. Comorbidities

Sugerman et.al. examined the relationship between diabetes and hypertension
in a cohort of severely obese patients prior to and following GBP. The effects of race,
age, gender, percent of excess weight loss, and the relationship of comorbidities such
as obstructive sleep apnea and venous stasis were observed. The results suggested that
the length of time with obesity was positively correlated with the incidences of
diabetes and hypertension. The patients with a better resolution of hypertension and
diabetes proved to have a greater percentage of excess weight loss and tended to be
younger and Caucasian. African American patients did not lose weight as efficiently
as Caucasians, 58 kg± 16 and 69 kg± 18, respectively (Sugerman HJ, Wolf LG, Sica
DA, Clore JN, 2003). These ethnic differences are important to address to better
promote weight loss and health outcomes following weight loss surgery, particularly
among African Americans.
Studies have demonstrated significant improvements in cardiovascular risk
factors and diabetes among Caucasian morbidly obese patients following GBP
(Sjostrom L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B,
Dahlgren S, Larsson B, Narbro K, Sjostrom CD, Sullivan M, Wedel H, 2004). Similar
studies in other ethnic groups remain limited. This might be related to the less frequent
use ofbariatric surgery in minority populations (Choban P, Lu B, Flancbaum L, 2000;
Livingston EH, Ko CY, 2004). Although there might be metabolic differences
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between morbidly obese African Americans and Caucasians, behavioral factors such
as dietary intake might also account for differences in weight reduction between
African Americans and Caucasians (Foster GD, Wadden TA, Swain RM, Anderson
DA, Vogt RA, 1999). Clarification of these differences is important for optimizing the
post-surgical treatment of morbidly obese African Americans.

Conclusion
Presently there is limited data examining the differences in weight loss, dietary
intake, and cardiovascular risk factors between African Americans and Caucasians
following GBP. This research project looked at these differences and did find that
African Americans lost less weight compared with Caucasians following GBP.
Dietary intake appears to be non-contributory to these weight loss differences.
However, despite smaller weight losses among African Americans, cardiovascular
improvements were similar between each race. Further research is essential to better
improve postoperative GBP outcomes among different racial groups.
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Appendix B

Common Dietary Stages Following Bariatric Surgery
Stage I (does not include fluid provided by intravenous infusion)
Food Type: Water
Duration: 0-1 day
Begin: Postoperative day 1
End: Postoperative day 1
Amount: 1-2 oz/hr
Fluid Goal: 14-32 oz/d (based on 14-16 waking hours)
Protein Goal: 0 g/d

Stage II
Food Type: Clear liquids
Non-caloric, decaffeinated, and noncarbonated beverages
Duration: 1-2 days
Begin: Postoperative day 1-2
End: Postoperative day 2-3
Amount: 2-3 oz/hr
Fluid Goal: 32-48 oz/d (based on 14-16 waking hours)
Protein Goal: 0 g/d

Other Suggestions:
Decaffeinated, noncarbonated, sugar-free beverages

Stage III
Food Type: Full liquids
Liquids containing high biological value protein
Nonfat or low-fat milk, low-fat creamed soups, blended and
strained sugar-free pudding and custard, blended low-fat cottage
and ricotta cheese
Some protocols recommend adding additional protein to these drinks
through powdered skim milk or powdered egg white (approximately 1
Tbsp per serving)
Duration: 14-21 days/2-3 weeks
Begin: Postoperative day 2-4
End: Postoperative day 16-25/week 2.5-3.5
Amount: 3-6 servings of 4-8 oz/d
Fluid Goal: 48-i2 oz/d, or based on estimated needs
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(Cont)
.
Protein Goal: 60-80 g/d, or based on estimated needs

Other Suggestions:
Sip all liquids slowly, limit to approximately 8 oz/hr

Stage IV
Food Type: Pureed/ground/diced foods
Generally foods allowed include only meat, poultry, fish, tofu and
dairy products
Starches: fruits and vegetables are typically excluded from this
stage although
soft fruits and vegetables have been included in
some protocols
Duration: 21-42 days/3-6 weeks
Begin: Postoperative day 17-26/week 2.5-3.5
End: Postoperative day 38-68/week 5.5-10
Amount: 2-3 oz of pureed/ground/diced food taken 3-5 times/d
Fluid Goal: 48-72 oz/d, or based on estimated needs
0-2 8-oz servings of full liquids (Drinks containing high biological
value protein)
Protein Goal: 60-80 g/d, or based on estimated needs

Other Suggestions:
Ground beef and shellfish might be difficult to tolerate
Eat slowly: 10 minutes/oz
Chew food thoroughly
Drink fluids at least 1 hour after meals
Stage V
Food Type: Small meals/snacks, consisting oflow-fat solids
Duration: Ongoing
Begin: Postoperative day 38-68/week 4.5-10
End: Ongoing
Amount: Typically based on the American Diabetes Association food exchange list.
Number of servings tolerated is widely variable by individual.
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(Cont)
SAMPLE MEAL PLAN (recommendations might vary based on individual
filedU
Starch: 3-7 exchanges
Fruit (soft): 2-3 exchanges
Vegetable: 2-4 exchanges
Milk: 1 exchange
Meat: 6-9 exchanges

Fat: 1-5 exchange
Fluid Goal: 48-72 oz/d, or based on estimated needs
Protein Goal: 60-80 g/d, or based on estimated needs

Other Suggestions:
Make protein the priority food
Allow a minimum of 10 minutes per ounce of food, or 30 minutes per 3
ounces
Often hard starches such as toast and crackers are better tolerated than
plain bread
Peel fresh vegetables and fruit when beginning to add in these foods

Problematic foods typically include the following:
Red meat, ground beef, dry meats, shellfish, cores, hard skins
(such as from an apple), seeds, membranes (particularly from
thick-skinned fruits and vegetables), popcorn kernels, nuts,
seeds, rice, and pasta

(Above dietary stages adapted from the Betsy Lehman Center Expert Panel on
Weight Loss Surgery Report)
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